A detailed history of Cassia Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cassia Capital Partners, LLC holds 16,315 shares of PFE stock, worth $424,516. This represents 0.31% of its overall portfolio holdings.

Number of Shares
16,315
Previous 17,133 4.77%
Holding current value
$424,516
Previous $479,000 1.46%
% of portfolio
0.31%
Previous 0.32%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$27.7 - $31.39 $22,658 - $25,677
-818 Reduced 4.77%
16,315 $472,000
Q2 2024

Jul 19, 2024

SELL
$25.26 - $29.6 $116,423 - $136,426
-4,609 Reduced 21.2%
17,133 $479,000
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $197,074 - $226,304
7,612 Added 53.87%
21,742 $603,000
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $8,884 - $11,539
-340 Reduced 2.35%
14,130 $406,000
Q3 2023

Oct 16, 2023

BUY
$32.09 - $37.51 $10,942 - $12,790
341 Added 2.41%
14,470 $479,000
Q2 2023

Jul 20, 2023

BUY
$36.12 - $41.79 $510,339 - $590,450
14,129 New
14,129 $518,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $9,846 - $12,019
-225 Reduced 3.18%
6,841 $299,000
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $465 - $551
10 Added 0.14%
7,066 $370,000
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $5,856 - $7,256
128 Added 1.85%
7,056 $365,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $286,264 - $424,340
6,928 New
6,928 $409,000
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $205,473 - $263,948
-5,235 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $187,988 - $212,959
5,235 New
5,235 $205,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $146B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cassia Capital Partners, LLC Portfolio

Follow Cassia Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cassia Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cassia Capital Partners, LLC with notifications on news.